Thomas Büttner

Autosomal dominant cerebellar ataxia: Phenotypic differences in genetically defined subtypes?

Lüdger Schöls, Georgios Amoiridis, Thomas Büttner et al. · Annals of Neurology · 1997 · 327 citations

S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction

Thomas Büttner, Stephan Weyers, Thomas Postert et al. · Stroke · 1997 · 260 citations

Knowing no fear

Reiner Sprengelmeyer, Andrew W. Young, Ulrike Schröeder et al. · Proceedings of the Royal Society B Biological Sciences · 1999 · 218 citations · Full text

Neuropsychology, Fear Appeals, Affective Neuroscience +20

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

Thomas Müller, Thomas Büttner, Ali-Farshad Gholipour et al. · Neuroscience Letters · 2003 · 201 citations

Medicine, Parkinson Disease, Mild Symptomatic Benefit +4

Elevated Plasma Levels of Homocysteine inParkinson’s Disease

W. Kuhn, R. Roebroek, Henk J. Blom et al. · European Neurology · 1998 · 170 citations

Metabolic Syndrome, Disease Mechanism, Cardiovascular Disease +14